#MyastheniaGravisAwarenessMonth
LightNews LightNews
mgnews.bsky.social
June is here… and so is our voice.
It’s Myasthenia Gravis Awareness Month! Follow along: https://bit.ly/4mEgIn0

#MyastheniaGravisAwarenessMonth #MGStrong #MGWarrior #MGAwareness #Bionews
June 2, 2025 at 3:03 PM
sleepypotatoes.bsky.social
Started off Myasthenia Gravis awareness month with my monthly IVIG plasma infusions.
#myastheniagravis
#myastheniagravisawareness
#myastheniagravisawarenessmonth
#ihaveheardofmg
#mgstrong
#autoimmunedisease
#iviginfuisons
June 2, 2025 at 10:18 PM
abfbrain.bsky.social
@Medscape.com reports Imaavy is approved for treating generalized myasthenia gravis (gMG). Imaavy blocks production of the protein FcRn. Clinical trials showed significantly reduced symptoms; results maintained after a 20-month follow-up. #MyastheniaGravis #MyastheniaGravisAwarenessMonth #BrainSky
Research Discovery: The FDA has approved a new drug, Imaavy, to treat generalized myasthenia gravis (gMG). Diseases Affected: Generalized Myasthenia Gravis (gMG)  Key Findings: Patients with gMG produce antibodies that attack their own cells. This autoimmune disease is made worse by a protein called FcRn, which helps antibodies survive longer. Normally that’s a good thing, but for people with gMG, those antibodies are harmful. Imaavy works by blocking production of the protein FcRn. What’s Next: Imaavy’s approval means that it can be administered to adults and teens aged 12 years and up who have tested positive for anti-acetylcholine receptor or anti-muscle-specific kinase antibodies.
June 9, 2025 at 5:55 PM
ukneqasiia.bsky.social
June is Myasthenia Gravis Awareness Month 🎗️

This rare neuromuscular autoimmune disorder affects 1 in 100,000 people in the UK, and with testing and symptom management many can go into remission.

Find more info here: www.myaware.org

#MyastheniaGravis #MyastheniaGravisAwarenessMonth
June 2, 2025 at 10:30 AM